Programmed translation arrest controlled by nascent peptides and antibiotics
由新生肽和抗生素控制的程序化翻译停滞
基本信息
- 批准号:8917273
- 负责人:
- 金额:$ 30.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-30 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmino AcidsAmino Acyl Transfer RNAAntibiotic ResistanceAntibioticsBacterial InfectionsBinding SitesCellsCistronsGenesInvestigationKnowledgeMacrolide AntibioticsMacrolide-resistanceMacrolidesModern MedicineMolecularMolecular WeightPeptide AntibioticsPeptidesPharmaceutical PreparationsPhysiologicalPropertyRegulationResistanceRibosomesRoleSignal TransductionStructureSystemTranslationsclinically relevantcofactorcombatleucylargininenovel strategiespathogenprogramspublic health relevanceresistance generesponsesensorsmall moleculetool
项目摘要
DESCRIPTION (provided by applicant):
ABSTRACT The ribosome can functionally respond to specific nascent peptides. Such response, which can be additionally affected by small molecular weight cofactors, is a key component of the mechanism of control of important bacterial and eukaryotic genes. However, the molecular mechanisms of recognition of the regulatory nascent peptide and cofactor and the basic principles of the ribosomal response are poorly understood. Expression of a number of inducible antibiotic resistance genes in bacterial pathogens is controlled by nascent peptide-dependent programmed translation arrest promoted by antibiotic. Recently, a distinct class of regulatory nascent peptides encoded in the regulatory cistrons of many macrolide resistance genes has been identified. The peptides of this class are characterize dby the presence of an 'RLR' (Arg-Leu-Arg) motif. Preliminary studies showed that the mechanism of programmed translation arrest directed by these peptides is principally different from all of the previously studied systems. Furthermore, nascent peptides as short as three or four amino acids were found to be sufficient to direct drug-dependent ribosome arrest thereby yielding the shortest known stalling peptides. Such minimalistic stalling nascent peptides and the knowledge of the exact binding site of the stalling cofactor (the inducing antibiotic) provide unprecedented tools for unraveling important fundamental aspects of the general mechanisms of nascent peptide- and small cofactor-controlled programmed translation arrest. In the three specific aims of this proposal we will 1) explore the structural features of the minimalist nascent peptide required for directing ribosome stalling, 2) analyze the role of the antibiotic cofactor in programmed translation arrest, and 3) unravel the mechanism of the stalling signal recognition and structural features of the ribosome in the arrested state.
描述(由申请人提供):
摘要 核糖体可以对特定的新生肽做出功能性反应。这种反应还受到小分子量辅助因子的影响,是重要细菌和真核基因控制机制的关键组成部分。然而,人们对调节性新生肽和辅因子识别的分子机制以及核糖体反应的基本原理知之甚少。细菌病原体中许多诱导型抗生素抗性基因的表达受到抗生素促进的新生肽依赖性程序性翻译停滞的控制。最近,已鉴定出在许多大环内酯类抗性基因的调节顺反子中编码的一类独特的调节新生肽。此类肽的特征是存在“RLR”(精氨酸-亮氨酸-精氨酸)基序。初步研究表明,这些肽指导的程序化翻译停滞的机制主要不同于所有先前研究的系统。此外,发现短至三个或四个氨基酸的新生肽足以指导药物依赖性核糖体停滞,从而产生已知的最短的停滞肽。这种简约的停滞新生肽和对停滞辅因子(诱导抗生素)精确结合位点的了解,为阐明新生肽和小辅因子控制的程序性翻译停滞的一般机制的重要基本方面提供了前所未有的工具。在该提案的三个具体目标中,我们将 1) 探索指导核糖体停滞所需的最小新生肽的结构特征,2) 分析抗生素辅助因子在程序性翻译停滞中的作用,以及 3) 揭示停滞机制捕获状态下核糖体的信号识别和结构特征。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Binding of Macrolide Antibiotics Leads to Ribosomal Selection against Specific Substrates Based on Their Charge and Size.
大环内酯类抗生素的结合导致核糖体根据特定底物的电荷和大小进行选择。
- DOI:
- 发表时间:2016-08-16
- 期刊:
- 影响因子:8.8
- 作者:Sothiselvam, Shanmugapriya;Neuner, Sandro;Rigger, Lukas;Klepacki, Dorota;Micura, Ronald;Vázquez;Mankin, Alexander S
- 通讯作者:Mankin, Alexander S
Molecular basis for erythromycin-dependent ribosome stalling during translation of the ErmBL leader peptide.
ErmBL 前导肽翻译过程中红霉素依赖性核糖体停滞的分子基础。
- DOI:
- 发表时间:2014
- 期刊:
- 影响因子:16.6
- 作者:Arenz, Stefan;Ramu, Haripriya;Gupta, Pulkit;Berninghausen, Otto;Beckmann, Roland;Vázquez;Mankin, Alexander S;Wilson, Daniel N
- 通讯作者:Wilson, Daniel N
Protein accounting in the cellular economy.
细胞经济中的蛋白质核算。
- DOI:
- 发表时间:2014-04-24
- 期刊:
- 影响因子:64.5
- 作者:Vázquez;Mankin, Alexander S
- 通讯作者:Mankin, Alexander S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXANDER S MANKIN其他文献
ALEXANDER S MANKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXANDER S MANKIN', 18)}}的其他基金
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action
以独特的作用机制推进核糖体靶向抗菌肽
- 批准号:
10443921 - 财政年份:2022
- 资助金额:
$ 30.31万 - 项目类别:
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action
以独特的作用机制推进核糖体靶向抗菌肽
- 批准号:
10569098 - 财政年份:2022
- 资助金额:
$ 30.31万 - 项目类别:
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action
以独特的作用机制推进核糖体靶向抗菌肽
- 批准号:
10436039 - 财政年份:2021
- 资助金额:
$ 30.31万 - 项目类别:
Exploiting antibiotics to understand the ribosome and translation
利用抗生素来了解核糖体和翻译
- 批准号:
9897557 - 财政年份:2018
- 资助金额:
$ 30.31万 - 项目类别:
Exploiting antibiotics to understand the ribosome and translation
利用抗生素来了解核糖体和翻译
- 批准号:
10366000 - 财政年份:2018
- 资助金额:
$ 30.31万 - 项目类别:
Equipment Supplement Request for Purchasing Amersham Typhoon RGB Phosphorimager (for R35GM127134)
购买 Amersham Typhoon RGB 荧光成像仪(适用于 R35GM127134)的设备补充申请
- 批准号:
10386084 - 财政年份:2018
- 资助金额:
$ 30.31万 - 项目类别:
Context-specific action of antibiotics targeting the catalytic center of the bacterial ribosome
针对细菌核糖体催化中心的抗生素的特定作用
- 批准号:
9158354 - 财政年份:2016
- 资助金额:
$ 30.31万 - 项目类别:
Context-specific action of antibiotics targeting the catalytic center of the bacterial ribosome
针对细菌核糖体催化中心的抗生素的特定作用
- 批准号:
9332339 - 财政年份:2016
- 资助金额:
$ 30.31万 - 项目类别:
Molecular mechanisms of action of macrolide antibiotics
大环内酯类抗生素的分子作用机制
- 批准号:
8640960 - 财政年份:2013
- 资助金额:
$ 30.31万 - 项目类别:
Molecular mechanisms of action of macrolide antibiotics
大环内酯类抗生素的分子作用机制
- 批准号:
8482422 - 财政年份:2013
- 资助金额:
$ 30.31万 - 项目类别:
相似国自然基金
基于D-氨基酸改性拉曼探针的细菌耐药性快速检测
- 批准号:22304126
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
化瘀通络法通过SATB1/JUNB介导“氨基酸代谢网-小胶质细胞极化”调控脑缺血神经功能恢复的机制研究
- 批准号:82374172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
磷酸酶SHP2调控成纤维细胞支链氨基酸代谢在炎症性肠病相关肠纤维化中的作用机制研究
- 批准号:82300637
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氨基酸感应器GCN2调控Beclin-1介导的自噬缓解自身免疫性甲状腺炎的作用研究
- 批准号:82370792
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
催化不对称自由基反应合成手性α-氨基酸衍生物
- 批准号:22371216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Dissecting the Integrated Stress Response in tRNA Synthetase-Associated Neuropathies
剖析 tRNA 合成酶相关神经病的综合应激反应
- 批准号:
10647281 - 财政年份:2023
- 资助金额:
$ 30.31万 - 项目类别:
A cell model of YARS2-associated childhood-onset mitochondrial disease
YARS2 相关的儿童期发病线粒体疾病的细胞模型
- 批准号:
10575369 - 财政年份:2023
- 资助金额:
$ 30.31万 - 项目类别:
Investigating the Role of Seryl-tRNA Synthetase in Mitochondrial Biology and Human Recessive Disease
研究 Seryl-tRNA 合成酶在线粒体生物学和人类隐性疾病中的作用
- 批准号:
10750183 - 财政年份:2023
- 资助金额:
$ 30.31万 - 项目类别:
Understanding the Role of the Integrated Stress Response in tRNA Synthetase-associated Charcot-Marie-Tooth Disease
了解综合应激反应在 tRNA 合成酶相关夏科-马里-图思病中的作用
- 批准号:
10740335 - 财政年份:2023
- 资助金额:
$ 30.31万 - 项目类别:
Role of translational fidelity in cellular physiology of oral streptococci
翻译保真度在口腔链球菌细胞生理学中的作用
- 批准号:
10461572 - 财政年份:2022
- 资助金额:
$ 30.31万 - 项目类别: